Advair Pediatric Once-Daily

Summary

To demonstrate if once-daily dosing of ADVAIR 100/50 once-daily has superior efficacy and comparable safety compared with FP 100mcg once-daily in pediatric subjects 4 to 11 years of age with asthma.

Timeline

Start

2001-11

Primary completion

2004-01

Completion

2004-01

Publications

• Background This study has not been published in the scientific literature.

Drugs

Indications